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Misfolded-synuclein is a key factor in the pathogenesis of Parkinson’s disease (PD). However, knowledge about a physiological role for
the native, unfolded-synuclein is limited. Using brains ofmice lacking-,-, and-synuclein, we report that extracellularmonomeric
-synuclein enters neurons and localizes tomitochondria, interactswithATP synthase subunit, andmodulatesATP synthase function.
Using a combination of biochemical, live-cell imaging and mitochondrial respiration analysis, we found that brain mitochondria of -,
-, and-synuclein knock-outmice are uncoupled, as characterized by increasedmitochondrial respiration and reducedmitochondrial
membrane potential. Furthermore, synuclein deficiency results in reduced ATP synthase efficiency and lower ATP levels. Exogenous
application of low unfolded -synuclein concentrations is able to increase the ATP synthase activity that rescues the mitochondrial
phenotypes observed in synuclein deficiency. Overall, the data suggest that -synuclein is a previously unrecognized physiological
regulator of mitochondrial bioenergetics through its ability to interact with ATP synthase and increase its efficiency. This may be of
particular importance in times of stress or PDmutations leading to energy depletion and neuronal cell toxicity.
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Introduction
Mitochondria have multiple crucial roles in cell homeostasis. The
major function of this organelle is the production of energy in form
of ATP, but it is also linked to other cellular functions such as cal-
cium signaling and cell proliferation and differentiation (Griffiths
and Rutter, 2009). Mitochondrial dysfunction has been associated
with a number of disorders ranging from cancer to neurodegenera-
tion. A strong pathogenic link to mitochondrial health has been
established for Parkinson’s disease (PD), one of the most common
disabling and incurable neurodegenerative conditions. The major
histopathological hallmarks in PD are Lewy bodies, which are intra-
cellular deposits of misfolded, aggregated -synuclein fibrils (Spill-
antini et al., 1998). In order for these fibrillar structures to form,
monomeric -helical -synuclein must undergo a series of confor-
mational changes and oligomeric intermediates, a process that has
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Significance Statement
Misfolded -synuclein aggregations in the form of Lewy bodies have been shown to be a pathological hallmark in histological
staining of Parkinson’s disease (PD) patient brains. It is known thatmisfolded-synuclein is a key driver in PD pathogenesis, but
the physiological role of unfolded monomeric -synuclein remains unclear. Using neuronal cocultures and isolated brain mito-
chondria of-,-, and-synuclein knock-outmice andmonomeric-synuclein, this current study shows that-synuclein in its
unfoldedmonomeric form improves ATP synthase efficiency andmitochondrial function. The ability of monomeric-synuclein
to enhance ATP synthase efficiency under physiological conditions may be of importance when -synuclein undergoes the
misfolding and aggregation reported in PD.
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been reported to be toxic to the cell (Cremades et al., 2012;Angelova
et al., 2016; Deas et al., 2016).
Many studies have overexpressed -synuclein in a variety of
models tomimic-synuclein-induced pathogenesis. These stud-
ies have reported -synuclein-induced calcium homeostasis dys-
regulation, compromised synaptic transmission, dopaminergic
imbalances, and mitochondrial abnormalities (Hettiarachchi et
al., 2009; Venda et al., 2010; Luth et al., 2014). However, overex-
pression studies are unlikely to provide a clear insight into the
physiological roles of native unfolded -synuclein and its impli-
cations in disease-causing processes. Studies of a physiological
function of -synuclein in the nervous system are often con-
founded by the presence of two other members of the synuclein
family, -synuclein and -synuclein. The three synucleins pos-
sess a high degree of amino acid similarity, significantly overlap-
ping expression patterns, and intraneuronal localization. The
generation of synuclein triple knock-out (TKO)mice hasmade it
possible to investigate the physiological role(s) of -synuclein in
a synuclein-null background while avoiding a potential compen-
satory effect by endogenous - or -synuclein (Greten-Harrison
et al., 2010). These TKOmice do not display a strong phenotype
except for some age-dependent neuronal dysfunction, making
them a useful model with which to study the physiological func-
tion of exogenously appliedmonomeric-synuclein (Chandra et
al., 2004; Robertson et al., 2004).
Alpha-helical -synuclein has been reported to bind the inner
mitochondrial membrane, making a physiological role for -sy-
nuclein inmitochondrialmetabolismpossible (Guardia-Laguarta et
al., 2014; Robotta et al., 2014). Therefore, this study presents an
in-depth analysis ofmonomeric-synuclein-induced effects onmi-
tochondrial metabolism in the TKOmodel and provides a physio-
logical role of -synuclein in ATP synthase function.
Materials andMethods
Animals. Synuclein TKO, -synuclein knock-out (AKO), -synuclein
knock-out (BKO), -knock-out (GKO), /knock-out (A/GKO), and
matching wild-type (WT) mice on a pure C57BL/6J genetic background
(RRID:IMSR_JAX:000664) of either sex were produced and maintained
as described previously (Anwar et al., 2011). Sprague Dawley rat pups
1–3 d postpartum (University College London breeding colony; RRID:
RGD_734476) of either sex were used for neuronal cocultures and exper-
imental procedures were performed in full compliance with the United
Kingdom Animal (Scientific Procedures) Act of 1986.
Cell culture and synuclein species. Mixed cultures of cortical or mid-
brain neurons and glial cells were prepared from postnatal pups (day
1–3). The preparation, maintenance, and characterization of primary
neuronal cultures were performed according to the method published
by Gandhi et al. (2009). Neurons were easily distinguishable from glia:
they appeared phase bright, had smooth rounded somata and distinct
processes, and lay just above the focal plane of the glial layer.
Untagged recombinant human synuclein proteins were expressed in
E. coli and purified as described previously by us and others (Jakes et al.,
1994; Ninkina et al., 2012). Purified proteins were immediately ali-
quoted, snap-frozen, and kept at 80°C. An absence of oligomers and
higher-order aggregates in defrosted aliquots was confirmed by gel elec-
trophoresis. A protein sample was used for assays immediately after de-
frosting of an aliquot; 100 nM were applied unless otherwise stated.
Oxygen consumptionmeasurements. Intact mitochondria were isolated
from the brains of WT, TKO, and AKO mice a method of differential
centrifugation (Plun-Favreau et al., 2012) and resuspended in medium
containing 250 mM sucrose, 1 mM EDTA, and 19 mM Tris-HCl, pH 7.1.
Oxygen consumption was measured in a Clark-type oxygen electrode
(Hansatech) thermostatically maintained at 25°C containing the follow-
ing (in mM): 135 KCl, 10 NaCl, 20 HEPES, 0.5 KH2PO4, 1 MgCl2, and 5
EGTA, pH 7.1. Glutamate (5 mM), malate (5 mM), and sodium succinate
(5 mM) were added to allow basal respiration (V2). Data were obtained
using an Oxygraph Plus system with Chart recording software. Protein
levels were established using a Pierce BCA protein assay kit (recordings
were adjusted accordingly).
Live-cell imaging. Themitochondrialmembrane potential (m)was
measured by loading cells with 25 nM tetramethyl rhodamine methyl
ester (TMRM) in aHEPES-buffered salt solution (Invitrogen) for 40min
at room temperature. Measurements were obtained with a Zeiss 710
VIS CLSM equipped with a META detection system and a 40 oil-
immersion objective while keeping 40 nM TMRM in the imaging solu-
tion. TMRM was excited using the 560 nm laser line and fluorescence
was measured 580 nm. Z-stack images were obtained by confocal
microscopy and the basalmwasmeasured using Zen software (Zeiss).
Assessments of the mitochondrial membrane potential maintenance
through application of oligomycin, rotenone, and the uncoupler
carbonylcyanide-p-trifluoromethoxyphenylhydrazone (FCCP) were pe-
rformed through recordings from a single focal plane. The TMRM was
used in the redistribution mode to assess the m, so a reduction in
TMRM fluorescence represents mitochondrial depolarization.
Kinetic ATP measurements. To determine the ATP levels, primary co-
cultures were transfected with a mitochondrial ATP probe (mitAT1.03)
generated by Imamura et al. (2009) using Effectene (Qiagen) according
to the manufacturer’s instructions. The FRET was quantified by the 527:
475 nm ratiowith an excitation of 405 nmand a filter from515 to 580 nm
(Imamura et al., 2009; Holmstro¨m et al., 2013). ATP kinetics were as-
sessed in permeabilized primary cocultures. To permeabilize the trans-
fected cells, a buffer (0.137 M NaCl, 5 mM KCl, 0.7 mM NaH2PO4, 25 mM
Tris-HCl, pH 7.1) containing low concentration of digitonin (20 M)
was added to the cocultures. Upon permeabilization, the buffer and dig-
itonin were replaced by fresh buffer containingmitochondrial substrates
(5 mM glutamate and 5mMmalate). Cells were allowed to rest for at least
5 min before measurements were taken.
Biochemical ATPmeasurements. Total ATP levels weremeasured using
the ATP Assay Kit (Abcam, ab83355) and following the manufacturer’s
protocol. Tissue was sampled and immediately frozen using liquid N2
until experimental procedures were started. Quantification was per-
formed by colorimetric measurements (ODmax 570 nm).
NADH measurements. NADH autofluorescence was measured using
an epifluorescence inverted microscope equipped with a 40 fluorite
objective. Excitation light at a wavelength of 350 nm was provided by a
xenon arc lamp, with the beam passing through a monochromator
(Cairn Research). Emitted fluorescence light was reflected through a 455
nm long-pass filter to a cooled CCD camera (Retiga; QImaging) and
digitized to 12 bit resolution. Imaging data were collected and analyzed
using software from Andor (RRID:SCR_014461).
Mag-Fura2 measurements. To assess the ATP levels, which correlate
withMg2 changes, [Mg2] was imaged usingMag-Fura2 AM. Fluores-
cence imageswere acquired (30 s interval) on an epifluorescence inverted
microscope equippedwith a 20 fluorite objective (excitation at 340 and
380 nm). The emitted light was reflected through a 515 nm long-pass
filter to a cooled CCD camera (Retiga; QImaging) and digitized to 12-bit
resolution (Cairn Research). Andor iQ (RRID:SCR_014461) was used to
collect and analyze data.
Enzyme activitymeasurements. ATP synthase enzyme activitywasmea-
sured using an ATP synthase microplate kit (Abcam) according to the
manufacturer’s protocol. Briefly, brain mitochondria were isolated,
lysed, and the F0F1-ATPase was immunocaptured in the wells of the
96-wellmicroplate suppliedwith the kit. The hydrolysis of ATP toADP is
coupled to the oxidation of NADH to NAD, which can be detected by
a decrease in absorbance at 340 nm (30°C).Monomeric-synuclein (100
nM) was added immediately beforemeasurements were taken and results
were compared against control wells containing F0F1-ATPase with or
without oligomycin.
Proximity ligation assay. The -synuclein proximity ligation assay was
performed using the Duolink in situ red kit (mouse/rabbit; Sigma-Al-
drich; DUO92101) supplied by Sigma-Aldrich according to the manu-
facturer’s instructions. Human neuroblastoma cells (SH-SY5Y catalog
#94030304, RRID:CVCL_0019) and rat neuronal cocultureswere used in
this assay because the most robust commercially available monoclonal
antibodies against ATP synthase subunits are raised in mice, which is
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preventing the use of TKOprimary neuronal cultures. Cells were exposed
to -synuclein for 1 h at 37°C before fixation. ATP synthase -subunit
antibody (Abcam catalog #ab14748, RRID:AB_301447) was omitted
for the control proximity ligation assay (PLA). Please note that the
antibody raised against -synuclein (Abcam catalog #ab138501, RRID:
AB_2537217) does not detect endogenous rat -synuclein.
Coimmunoprecipitation (co-IP) and Western blotting. For co-IP, rat
brain mitochondria were isolated (Plun-Favreau et al., 2012). The mito-
chondrial sample was divided and one part was exposed to monomeric
-synuclein for 15min. Immunoprecipitating antibodies (anti--synuclein
antibody; Abcam catalog #ab138501, RRID:AB_2537217) were coupled to
Dynabeads Protein A (10006D) according to the manufacturer’s protocol
(Thermo Fisher Scientific). It should be noted that the anti--synuclein
antibodybindshuman-synucleinonly (e.g., the exogenous appliedmono-
meric -synuclein; Abcam) and not the endogenous rat -synuclein. The
coupled beads were exposed to the mitochondrial samples and the eluents
(and inputs were separated by SDS-PAGE, transferred to nitrocellulose, and
probed for ATP synthase subunit  (53 kDa; Abcam catalog #ab14748,
RRID:AB_301447) and -synuclein (predicted 14 kDa; Abcam catalog
#ab138501, RRID:AB_2537217).
Statistical analysis. Statistical analysis and exponential curve fitting
were performed using Origin 9 (Microcal Software; RRID:SCR_014212)
software. Experimental data are shown asmeans	 SEM. Statistical anal-
ysis between samples was performed using a one-way ANOVAwith Bon-
ferroni correction. Differences were considered to be significantly
different if p
 0.05.
Results
Lack of,,-synuclein leads to a decreased mitochondrial
membrane potential
Primary neuron/glia cocultures were prepared from the cerebral
cortex of WT, TKO, and AKO mice (Anwar et al., 2011) and the
m was assessed as an indicator of mitochondrial health and
metabolic function. The m of neurons and astrocytes were
analyzed separately because these cell types have differentmetab-
olisms and could exhibit different responses to unfolded proteins
(Abramov et al., 2004).UsingTMRMas a fluorescent indicator of
m, it was found that the basalmwas significantly lower in
both AKO astrocytes (70	 3%, n 20 cells; p
 0.05) and TKO
astrocytes (63	 3%, n 50 cells; p
 0.001) compared with the
basal m values for these cells in cultures prepared from WT
mice (normalized to 100%, n 39 cells; Fig. 1A). Similar results
were obtained in neurons of AKO (70	 11%, n 22, 3 indepen-
dent experiments, p
 0.05) and TKO (85	 3%, n 72 cells, 3
independent experiments; p 
 0.05) mice compared with the
basal m values for these cells in cultures prepared from WT
mice (normalized to 100%, n  39 cells; 3 independent experi-
ments). Impaired mitochondrial respiration can induce a switch
of the F0F1-ATPsynthase to work in reverse mode (ATPase) to
maintain the m (Yao et al., 2011). The F0F1-ATPsynthase
inhibitor oligomycin was used to test whether synuclein defi-
ciency affects the mechanism of m maintenance. Both, WT
and TKO cells showed no decrease of m in response to the
F0F1-ATPsynthase inhibitor oligomycin (2 g/ml), whereas sub-
sequent inhibition of complex I by rotenone (5 M) caused a
rapid loss of potential (Fig. 1B). Complete depolarization was
achieved in all TKO and WT cells by the addition of the mito-
chondrial uncoupler FCCP (1 M). Therefore, although sy-
nuclein deficiency results in a lower mitochondrial membrane
potential, it does not alter the mechanism ofmmaintenance.
To investigate whether -synuclein affects the m, ex-
Figure 1. Mitochondrial membrane potential is lower in synuclein-deficient cells and can be rescued by exogenousmonomeric-synuclein. A, Basalmwas quantified inWT, AKO, and TKO
cells.B, Representative traces of TMRM fluorescence inWT and TKO primary cells after addition of oligomycin (2g/ml), rotenone (1M), and FCCP (1M). C, Representative images of cells loaded
with TMRM before and after-synuclein addition. *p
 0.05; ***p
 0.001; n 3 independent experiments. Scale bar, 20m.
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ogenous monomeric -synuclein (100 nM) was applied to
both cocultures before m was measured. The cultures were
preincubated for 10 min and analysis of the m revealed that
low concentrations of -synuclein raises the basal m signifi-
cantly in TKO cultures (astrocytes by 58	 5%; n 20 cells, p

0.001, neurons by 50	 14%, n 10 cells, p
 0.001), as well as in
WT (astrocytes by 51 	 9%; n  15 cells, neurons by 46 	 8%;
n 15 cells, p
 0.001) comparedwith basalm levels without
exogenous -synuclein (Fig. 1A,C).
Triple synuclein deficiency decreases NADH redox state
There are several possible explanations for the observed reduc-
tion inm in the absence of-,-, and -synuclein. Them
ismaintained by complexes of the respiratory chain, which trans-
fer electrons via redox reactions and transport protons across the
membrane, generating an electrical potential. This electrical
potential can depolarize in a number of situations, including
insufficient respiratory chain activity or uncoupled oxidative
phosphorylation. To investigate which of these factors caused the
observed lowerm, respiratory chain activity wasmeasured by
NADH autofluorescence (Bartolome´ and Abramov, 2015).
NADH is the electron donor for complex I, so NADH levels
correlate inversely to respiratory chain activity. For measure-
ments of the redox index, FCCP (1 M) was added to maximize
respiration and therefore minimize the mitochondrial NADH
pool. The addition of NaCN (1 mM) blocks mitochondrial respi-
ration and therefore maximizes the NADH pool in mitochon-
dria. This allowed the separation ofmitochondrial from cytosolic
NADH and total NADPH. The initial NADH autofluorescence is
then calculated as a percentage of this range (Fig. 2A). In addi-
tion, the total mitochondrial pool of NADH (maximum auto-
fluorescence minus minimum) may be taken as an indication of
the substrate availability for complex I.
We observed a significant decrease in the redox index of TKO
neurons and astrocytes, indicating an increased respiration rate
in these cells from 37.8	 3.9 in control (n 37 cells) to 21.8	
3.1 in TKO (n  49 cells) (p 
 0.001; Fig. 2B). The total mito-
chondrial pool of NADH in TKO neurons and astrocytes was
higher than in WT (132 	 12% of control; p 
 0.001; Fig. 2C).
This effectmight be due to an activation/upregulation of the TCA
cycle (that leads to an increased mitochondrial NADH pool) to
compensate for a higher rate of NADH consumption in the mi-
tochondria (lower redox level in the same experiment).
-Synuclein is a regulator of mitochondrial respiration
The lower m and NADH redox state in cultured TKO cells
suggest an altered mitochondrial respiration. Therefore, a more
direct measurement of respiration was performed in WT and
TKO brain mitochondria using a Clark-type oxygen electrode
(Fig. 3). Brain mitochondria were isolated from WT and TKO
mice and the basal rate of oxygen consumption was measured
through the application of TCA cycle substrates (5 mM malate
and 5mM glutamate), which allowed the assessment of complex I
activity and therefore mitochondrial respiration (V2). V2 respi-
ration was significantly higher (by 26 	 8.1%; n  36 measure-
ments; 8 experimental days, p 
 0.05; Fig. 3A,B) in TKO
mitochondria compared with WT mitochondria. Importantly,
the rate of V2 respiration was also significantly higher in AKO,
BKO, GKO, and A/GKO mice (n  9 measurements; 3 experi-
mental days; p
 0.05; Fig. 3B). This was repeated by application
of alternate TCA cycle substrates, malate and sodium pyruvate
(n 7measurements; Fig. 3C). These data are in agreement with
the previous NADH experiment, which also suggested increased
respiration in TKO.
Several other states can be assessed to understand mitochon-
drial respiration. Application of ADP to the mitochondria allows
the assessment of the V3 (ADP-dependent) state, representing
the oxygen consumption during maximal ADP phosphorylation
by the ATP synthase. Upon depletion of all ADP, mitochondrial
oxygen consumption slows down, corresponding to state V4
(ADP-independent or absent phosphorylation). These two states
allow the calculation of the respiratory control ratio (RCR). This
V3/V4 ratio indicates the degree of coupling between the mito-
chondrial respiratory chain activity and oxidative phosphoryla-
tion (Chance and Williams, 1955).
The RCR was found to be significantly lower in TKO mito-
chondria (23	 1.8% decrease compared with WT; n 17 mea-
surements; 8 independent experiments; Fig. 3D), indicating that
these mitochondria are uncoupled. This is the result of signifi-
cantly lower oxygen consumption in V3 in the TKO mitochon-
dria (17	 6%), with no significant changes in V4 (Fig. 3E).
-Synuclein affects ATP synthase efficacy
The oxygen electrode allows the analysis of ATP synthase effi-
ciency, which is expressed in form of the ADP:O ratio. This ratio
Figure 2. NADH autofluorescence measurements reveal increased respiration in TKO
cells. A, Representative traces of NADH in healthy cells. FCCP (1M) is applied tomaximize
respiration and therefore minimize the NADH pool; NaCN (1 mM) is added to block the
mitochondrial respiration and therefore maximize the NADH pool. B, Redox index is sig-
nificantly lower in TKO compared with WT cells. C, Mitochondrial pool of NADH is signifi-
cantly larger in TKO compared with WT cells, indicating normal substrate supply. *p

0.05; ***p
 0.001; n 3 experiments.
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Figure 3. TKO mitochondria are uncoupled, respire faster, and have a lower ATP synthase efficiency. A, Representative traces of oxygen consumption in the presence of mitochondrial
substrates (V2; 5 mM glutamate/malate). B, Quantification of basal respiration (V2) revealed a significantly faster respiration in synuclein-deficient mitochondria compared with WT
mitochondria (n  3 experiments). C, Application of the alternate TCA substrates malate and sodium pyruvate mirrored the higher V2 observed in B (n  3 experiments). D,
Quantification of RCR showed that TKO mitochondria are uncoupled and that-,-, or-synuclein lowers the RCR. E, Quantification of V3 and V4 of WT and TKO mitochondria with and
without -synuclein. F, Representative traces of oxygen consumption (V3) in the absence and presence of monomeric -synuclein. G, Quantification of ADP:O in WT and TKO
mitochondria in the presence and absence of -, -, or -synuclein. *p
 0.05; **p
 0.01; ***p
 0.001.
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expresses how much oxygen is consumed per nmole of ADP to
ATP conversion. The ADP:O ratio was significantly lower (25	
5%, n 17measurements; 8 independent experiments, p
 0.01)
in TKO compared with WT mitochondria, suggesting that oxi-
dative phosphorylation is less efficient in TKOmice (Fig. 3G). To
investigate whether -synuclein has a direct effect on the ATP syn-
thase efficiency, 100nM-synucleinwas addedandADP:Oassessed.
Alpha-,-, or-synucleinwas added to the oxygen electrode cham-
ber containingmitochondria and incubated for 60–90 s in the pres-
enceofTCAsubstrates.Thiswas followedby theapplicationofADP,
which allowed the ADP:O ratio to be calculated (Fig. 3F,G). In the
presenceofmonomeric-synuclein, a significant increase inADP:O
was observed in WT and TKO mitochondria (27	 6% and 36	
9%; respectively, n 6measurements, 3 independent experiments;
p
 0.001, p
 0.01; Fig. 3F). Importantly, - and -synuclein also
increase theADP:O significantly (Fig. 3F). TheRCRdecreases upon
-, -, or -synuclein addition. For example, the RCR decreases by
19 	 0.2% in WT and 14 	 0.4% in TKO mitochondria upon
-synuclein application (Fig. 3D). Further analysis of V3 and V4
revealed that application of -synuclein reduces V3 (ADP depen-
dent) by 18	 5.4% inWT and by 14	 4% in TKOmitochondria
while not altering V4 (ADP independent) (Fig. 3E). These results
suggest that synuclein deficiency or application of monomeric sy-
nuclein affects onlyADP-dependent respiration (V3),which further
suggests amonomeric synucleineffectonoxidativephosphorylation
rather than respiration.
It should be noted that, in TKO mitochondria, only the higher
concentration (100 nM) of -synuclein provided a significant in-
crease in the ADP:O ratio (36 	 12.5%, n  9 measurements; 3
independent experiments; p 
 0.05; Fig. 4A). These results were
mirrored in AKOmouse brain mitochondria, in which application
of 100 nM-synuclein increased the ADP:O by 31% (	3.7%, n 8
measurements, 3 independent experiments; p 
 0.01) compared
with the AKO control background (Fig. 4B). Mutated -synuclein
A30Pwas included to serve as a control-helical protein in the short
incubation experiments. It has been shown that this mutation
greatly impairs binding to phospholipids and, correspondingly, in-
teractionwith various phospholipidmembranes (Jensen et al., 1998;
Cole et al., 2002; Fortin et al., 2004). Importantly, A30P-synuclein
had no effect on ADP:O (Fig. 4C).
If the effect of synuclein on ADP:O is mediated through un-
coupling proteins (UCPs), then a UCP inhibition would prevent
the effect of synuclein. Inhibition of UCPs by GDP (500 M, n
3 experiments) did not change the ability of synuclein to increase
ADP:O, suggesting that the effect of synuclein on ADP:O is emit-
ted through an increased oxidative phosphorylation efficiency
and not through a UCP-mediated process (Fig. 4D).
All three synucleins were found to activate V2 (Fig. 4E). Pre-
incubation ofmitochondria with inhibitor of F0F1- ATP synthase
oligomycin (2g/ml) completely blocked the effect of synucleins
onV2 respiration,which suggests that activation of respiration by
all synucleins is due to an effect on oxidative phosphorylation
(Fig. 4F). Uncoupling of mitochondria with FCCP induces max-
imal respiration. Application of FCCP revealed that maximum
respiration is not affected by synuclein, suggesting that synuclein
does not affect the activity of mitochondrial ETC complexes
(Fig. 4G).
Together, these data suggest that monomeric -, -, and
-synuclein have a direct effect on oxidative phosphorylation and
ATP synthase efficiency.
Lack of synuclein leads to lower ATP levels
The lower ATP synthase efficiency in TKO as shown by ADP:O
should lead to decreased ATP levels in affected tissues. To deter-
mine whether an alteration in ATP synthase efficiency in TKO
mitochondria was sufficient to reduce ATP levels in tissues, ATP
levels in different brain regions of TKO andWTmice were assessed
using a colorimetric ATP assay, as described in the “Materials and
Methods” section. Itwas found that theATPconcentration incortex
and midbrain tissue of TKO mice was significantly lower (94.5 	
0.4% and 90.1 	 0.4%, respectively) than in those tissues of WT
mice (p 0.05, n 3; Fig. 5A).
Further evidence for the reduction of ATP level in TKO cells
came from monitoring mitochondrial ATP. Primary neuronal/
glial midbrain cultures were transfected with a FRET-based ATP
probe (Imamura et al., 2009), allowing basal and kinetic changes
in ATP to be monitored (Fig. 5C). The basal fluorescent signal
reflects mitochondrial ATP levels and is in agreement with the
data generated in Figure 5A because mitochondrial ATP levels
were significantly reduced by 13 	 1.3% (n  5 experiments,
p
 0.05) in TKO cells (Fig. 5B).
The transfected cells were then permeabilized in pseudo-
intracellular solution (Fig. 5C) and the changes of ATP levels
were assessed in the presence of mitochondrial substrates (5 mM
malate and 5 mM glutamate), ADP, and oligomycin (2 g/ml)
with or without -synuclein (Fig. 5D,E). The addition of ADP
leads to an increase in the ATP level and therefore an increase in
ATP fluorescence as the ATP synthase converts ADP to ATP. No
significant differences were detected in the amplitude of ATP
fluorescence in TKO compared with WT upon ADP addition
(Fig. 5F). However, application of 100 nM -synuclein mono-
mers resulted in an increase in ATP fluorescence after ADP addi-
tion in both WT and TKO mitochondria (Fig. 5E,F).
The energy capacity of the cell is defined as the time between
cessation of ATP production and the time of energetic collapse
due to total ATP depletion and inability to maintain calcium
homeostasis (Abramov et al., 2007; Yao et al., 2011). Live-cell
imaging of the fluorescent probe MagFura-2 was used to assess
the energy capacity of WT and TKO primary cocultured cells.
Mg2 is released fromMgATPupon the hydrolysis of ATP, so the
measurement of cellular free magnesium ([Mg2]c) using the
Mg2-sensitive fluorescent probe MagFura-2 can be used as an
indication of ATP consumption (Leyssens et al., 1996; Yao et al.,
2011). Application of inhibitors of glycolysis and/or oxidative
phosphorylation blocks ATP production in cells, which eventu-
ally leads to ATP depletion and subsequent Mg2 release and an
increase in Mag-Fura fluorescence (Fig. 6A).
To estimate the overall ATP consumption inWT andTKOneu-
ronal/glial cocultures, inhibitors of glycolysis (iodoacetic acid, 20
M) and F1F0-ATP synthase (oligomycin, 2 g/ml) were applied
simultaneously. As shown in Figure 6B, complete inhibition of ATP
production induced an earlier increase in Mag-Fura fluorescence,
reflecting a faster energetic collapse in TKO cells (44.8	 1.9 min)
compared withWT (97.1	 5.1min; p
 0.001; n 3 independent
experiments; Fig. 6B,E), which can be explained by the previously
described lower ATP levels in these cells.
The ATP synthase can be reversed to the F1F0-ATPase by
mitochondrial respiration inhibitors, which results in a max-
imal ATP consumption rate (Campanella et al., 2008). To
force the cells into the F1F0-ATPase mode, iodoacetic acid (20
M) and an inhibitor of the respiratory chain (NaCN, 1 mM)
were applied (Fig. 6A). Under these conditions, the rate in
[Mg2]c as a function of ATP consumption and time to cell
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Figure 4. ATP synthase efficiency can be rescued by application ofmonomeric synuclein.A, Quantification of the effects on ADP:Owhen 35 or 100 nMmonomeric-synuclein is applied toWT or
TKO mitochondria (n 3 experiments). B, Quantification of AKO ADP:O in the presence or absence of -synuclein. C, Quantification of the effects on ADP:O when monomeric mutant A30P
-synuclein is applied to TKO mitochondria. D, Quantification of ADP:O in the presence of GDP (a UCP inhibitor) and/or -synuclein. E, Representative traces of V2 activation by -, -, or
-synuclein. E, Representative traces of oxygen consumption upon oligomycin,-,-, or-synuclein and FCCP application.G, Quantification of FCCP inducedmaximum respiration in the presence
of,, or-synuclein. *p
 0.05; **p
 0.01; ***p
 0.001.
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collapse was faster in WT cells (23.2 	 1.2 min) compared
with TKO (46	 0 min; Fig. 6C,E). These observations suggest
that F1F0-ATPase activity is lower in TKO than in WT cells.
Interestingly, preincubation of TKO cocultures with 100 nM
-synuclein led to a significant reduction in the time until
energy collapse (26.2 	 0.9 min; p 
 0.001), matching the
observations in WT cultures (23.2 	 1.2 min; Fig. 6D,E, 3
independent experiments, p NS). These results suggest that
exogenous -synuclein is able to rescue ATPase activity in
TKO cells back to control levels.
These data suggest that the ATPase activity is reduced in
-synuclein-deficient cells and that-synuclein can increase AT-
Pase activity. Therefore, -synuclein is also able to modulate the
activity of complex V in ATPasemode in addition to the previous
data showing its ability to modulate the activity and efficiency of
ATP synthase.
-Synuclein increases ATP synthase activity
Theobtaineddata suggest that-synuclein acts on theATP synthase
and its activity. To verify whether -synuclein regulates ATP syn-
Figure5. ATPlevelsinTKObraintissuearesignificantlylowercomparedwithWT.A,QuantificationofATPlevelsinWTandTKOcortexandmidbraintissuebycolorimetricmeasurements(n3).B,Quantificationofbasal
ATP levels inWTandTKOneuronal coculturesusingaFRET-basedmitochondrialATPprobe (n5).C, Representative imagesof cells transfectedwith themitochondrialATPprobebeforeandafterpermeabilization.D,E,
RepresentativetraceofkineticchangesinmitochondrialATPofWTcells inthepresenceofmitochondrialsubstrates(malate/glutamate),ADP,andoligomycinintheabsence(D)orpresence(E)ofmonomeric-synuclein.F,
ATPamplitudequantificationuponADPapplicationinthepresenceorabsenceofmonomeric-synucleininWTorTKO(n4).*p
0.05;***p
0.00.Scalebar,10m.
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Figure 6. ATP synthase is more efficient in the presence of monomeric-synuclein. A, Diagram displaying inhibitory effects of oligomycin, iodoacetic acid (IAA), and NaCN. B, Representative
Mag-Fura traces of WT and TKO cocultures after treatment with oligomycin and IAA, which block oxidative phosphorylation and glycolysis. These inhibitors allow assessment of the total ATP pool.
C, Representative Mag-Fura traces of WT and TKO cocultures after treatment with NaCN and IAA, which blocks mitochondrial respiration and glycolysis. D, Representative Mag-Fura traces of TKO
cocultures after treatment with NaCN and IAA in the presence of 100 nM monomeric-synuclein. E, Quantification of the time until collapse in cells exposed to oligomycin and IAA, NaCN and IAA,
NaCN, or IAA in the presence of monomeric-synuclein. n 3 experiments; ***p
 0.001.
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thase activity, brain mitochondria were isolated and the F0F1-
ATPase immunocaptured in the wells of a microplate, as described
in the “Materials andMethods” section. This assay allowsmeasure-
ments of-synuclein effects onATP synthase activity in the absence
of any other mitochondrial proteins. Monomeric -synuclein was
added to the wells immediately before absorbance was measured at
340 nm. The addition of -synuclein led to a significant increase in
ATP synthase activity (36 	 5.8%) compared with control wells
(100	 8%; Fig. 7A; n 4 experiments; p
 0.05). This assay pro-
vided evidence that -synuclein is able to act directly on the ATP
synthase independent of any other mitochondrial proteins.
Direct interaction of monomeric -synuclein and ATP
synthase subunit 
To provide further evidence that -synuclein has a direct effect
onATP synthase, a PLA, which detects in situ protein interaction,
was performed. Antibodies against ATP synthase subunit 
(ATP5A) and -synuclein were used in this assay. Human neu-
roblastoma cells (SH-SY5Y) and rat neuronal cocultures were
used to provide evidence for a protein interaction across two
species. It should be noted that the most robust commercially
available monoclonal antibodies against ATP synthase subunit 
are raised inmice, which prevents the use of TKOmouse primary
neuronal cultures. SH-SY5Y cells and rat primary cocultures
were preexposed to exogenous -synuclein for 1 h at 37°C. An
interaction of exogenously applied -synuclein and ATP syn-
thase subunit is represented by fluorescence emission at 624nm
in form of distinct puncta (Fig. 7B). The PLA signal provided
evidence that that -synuclein not only penetrates cells, but also
localizes to the mitochondria in a close proximity (
40 nm) to
the ATP synthase subunit  (Fig. 7B).
To provide further evidence for a direct interaction between
the exogenous monomeric -synuclein and ATP synthase sub-
unit , rat brain mitochondria were exposed to exogenous hu-
man monomeric -synuclein for 15 min and lysates were
subjected to immunoprecipitation with an antibody specific for
-synuclein. The immunoprecipitates were then probed with an
ATP synthase subunit  antibody (ATP5A). The membrane was
then stripped and reprobed with an -synuclein antibody to vi-
sualize its presence. As shown by PLA, an interaction between
monomeric -synuclein and ATP5A was observed (Fig. 7C).
These results strongly suggest that exogenously applied
-synuclein interacts directly with ATP synthase.
Figure 7. Monomeric -synuclein binds and improves ATP synthase efficiency. A, Quantification of ATP synthase activity in the presence and absence of 100 nM monomeric -synuclein.
Bi, Representative images of PLA showing -synuclein and ATP synthase subunit  interaction in SH-SY5Y and rat neuronal cocultures. The nucleus is stained in blue (DAPI). Note that the
-synuclein antibody does not detect endogenous rat -synuclein. Bii, Representative image of a technical control in which one primary antibody was omitted. C, Western blot showing an
interaction between-synuclein and the ATP synthase-subunit (ATP5A) in the eluent that was exposed to exogenous-synuclein. The membrane was reprobed with the antibody specific for
-synuclein to visualize the bait used for the co-IP.D, Schematic diagram illustrating the effects of-synuclein deficiency and rescuewithin themitochondria. *p
 0.05; n 4 experiments. Scale
bar, 10m.
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Discussion
Agrowingbodyof evidence suggests thatpathologicalmodifications
of the structure, expression, and/or intracellular localization ofmis-
folded aggregated -synuclein cause mitochondrial dysfunction(s),
which becomes a crucial event in the pathogenesis of PD and other
synucleinopathies. In contrast, information about the physiological
effects of unfolded monomeric -synuclein in mitochondria is
scarce. This current study assessed the physiological role(s) of this
protein in brainmitochondria by examining the effects of recombi-
nant monomeric -synuclein at low concentrations on cells and
mitochondria obtained from WT and TKO mice lacking all three
members of the synuclein family, in which no functional compen-
sation by endogenous synucleins can occur.
It was found that AKO and TKO neurons and astrocytes have
a significant lower m. Further, TKO mitochondria respire
faster, as established by oxygen electrode measurements and
NADH redox index calculations (complex I activity). These
lower m and faster respiration were not due to a diminished
mitochondrial substrate supply because the NADH pool was
higher in TKO cells.
Oxygen electrode measurements confirmed a faster V2 in
TKO brain mitochondria. These data are consistent with the
lower RCR values in TKO mitochondria, indicating an uncou-
pling between oxidative phosphorylation and respiration. In
agreement with the previous sets of data, the APD:O ratio was
found to be significantly lower in TKOmitochondria, indicating
that oxidative phosphorylation/ATP synthase activity is de-
creased in these cells. The finding of a decreased oxidative phos-
phorylation/ATP synthase activity was further supported by a
lower ATP pool in TKO cells.
To establish whether the observed cellular effects were caused
by a lack of -synuclein and were not an indirect consequence or
downstream effect of synuclein deficiency, exogenous mono-
meric -synuclein was applied. Previous studies have shown that
-synuclein can pass membranes and associate with mitochon-
dria (Cremades et al., 2012; Guardia-Laguarta et al., 2014; Ro-
botta et al., 2014). This current study used low physiological
doses of monomeric -synuclein (Sierks et al., 2011) to establish
whether themitochondrial dysfunction induced by synuclein de-
ficiency could be reversed.Here, it was shownbyPLA that recom-
binant, exogenously applied -synuclein is able to penetrate cells
(human and rat origin) and localize to themitochondria, which is
in agreement with previous studies. Furthermore, the PLA and
co-IP provided strong evidence of a direct interaction between
monomeric -synuclein and the ATP synthase subunit .
Application of recombinant -synuclein led to an increase in
ATP levels through improving ATP synthase efficiency (as shown
by the ADP:O ratio). This was specific to its WT form because
A30P synuclein did not result in an improved ATP synthase effi-
ciency. Application of exogenous -synuclein was able to rescue
the mitochondrial phenotype of the TKO model significantly.
Complete restoration to WT levels was not always achieved and
this may be attributed to concentration-dependent and/or time-
dependent effects of exogenously added protein in this experi-
mental paradigm.Nevertheless, we were also able to demonstrate
that, whenATP synthase is acting as anATPase, the application of
-synuclein was able to increase the activity of the ATPase. We
have provided evidence that the effect of -synuclein on ATP
efficiency is due to a direct effect of -synuclein on the ATP
synthase itself.
One of the possible explanations for the increased capacity in
oxidative phosphorylation may be an -synuclein-mediated ef-
fect on mitochondrial UCPs. However, synuclein works through
a UCP-independent mechanism for two reasons: (1) UCP inhi-
bition by GDP does not alter the effect of -synuclein on ADP:O
and (2) if synuclein improves mitochondrial coupling, then it
should increase the RCR upon application of synuclein, but the
RCR decreases.
Increased ATP synthase efficiency may be particularly impor-
tant for the proper function of remote cellular compartments
such as presynaptic terminals, which require a high energy output
from a limited number of available mitochondria. High levels of
-synuclein in presynaptic terminals, together with its ability to
regulate ATP synthase activity and mitochondrial ATP produc-
tion positively, may be crucial to maintaining the bioenergetic
needs of neuronal synapses. This may represent a mechanism for
monomeric -synuclein involvement in synaptic function. It is
feasible that this mechanism may become vital for functional
compensation when the efficiency of other intraneuronal pro-
cesses start declining and might, at least in part, explain why
synuclein-deficient mice develop an age-dependent synaptic pa-
thology (Al-Wandi et al., 2010; Greten-Harrison et al., 2010; An-
war et al., 2011). Interestingly, -synuclein has been implicated
in other synaptic processes such as synaptic vesicle exocytosis and
endocytosis (Burre´ et al., 2010; Vargas et al., 2014), again, not as
a functionally critical component, but rather, as a factor increas-
ing their efficiency.
Many PD models have been linked to oxidative stress, mito-
chondrial dysfunction, and synaptic deficits (Parihar et al., 2008;
Gandhi et al., 2009; Gandhi and Abramov, 2012; Angelova et al.,
2016). The observed pathology may be due to a toxic gain of
function of the aggregated -synuclein protein or perhaps a loss
of its physiological role.
Our study provided clear evidence that -synuclein not only
interacts with the ATP synthase, but also acts as a direct regulator
of ATP synthase efficiency. This allows the hypothesis that
-synuclein regulates ATP synthase activity and ATP levels, but
in times of stress or PD mutations, may lead to neuronal cell
toxicity.
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